Skip to main content
Log in

Appearance of enkephalin-immunoreactivity in rat adrenal medulla following treatment with nicotinic antagonists or reserpine

  • Published:
Cell and Tissue Research Aims and scope Submit manuscript

Summary

Various neuroendocrine factors known to be important in the regulation of adrenal catecholamine biosynthesis were investigated for possible effects on enkephalin-like immunoreactivity (Enk-IR) in the adrenal medulla of the rat. In normal rats, the adrenal chromaffin cells were not stained for either methionine (met-) or leucine (leu-) Enk-IR. Staining for Enk-IR appeared in many chromaffin cells following denervation of the adrenal or treatment of rats with the nicotinic receptor antagonists chlorisondamine or pempidine. These observations suggest that splanchnic nerve activity normally depresses the levels of enkephalin-like peptides in chromaffin cells through a trans-synaptic mechanism involving acetylcholine release and nicotinic receptor stimulation.

Paradoxically, treatment with reserpine also increased Enk-IR in chromaffin cells. However, this increase did not appear to result from the well known effect of reserpine to increase presynaptic nerve firing and tyrosine hydroxylase (TOH) activity, since no increase in Enk-IR was observed following treatment with phenoxybenzamine or 6-hydroxydopamine, drugs which also increase TOH activity through trans-synaptic mechanisms. The reserpine effect also did not appear to be mediated by a stress-induced increase in glucocorticoid hormones since glucocorticoid therapy alone did not increase adrenal Enk-IR. It is suggested that the increase in adrenal Enk-IR following reserpine may result from a direct action of reserpine on chromaffin cells.

In general, these studies demonstrate that the characterization of neuronal phenotypes in vivo by immunocytochemistry may depend on the physiological state of the animal at the time of sacrifice. These experiments also show that enkephalin-like peptides in the adrenal, like catecholamines, are subject to trans-synaptic regulation. However, the two systems appear to be differentially regulated and not all factors which regulate the amines influence the peptides, even though both are localized in the same cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bohn MC, Goldstein M, Black IB (1981) Role of glucocorticoids in expression of the adrenergic phenotype in rat embryonic adrenal gland. Dev Biol 82:1–10

    Google Scholar 

  • Carr LA, Moore KE (1968) Effects of reserpine and α-methyltyrosine on brain catecholamines and the pituitary-adrenal response to stress. Neuroendocrinol 3:285–302

    Google Scholar 

  • Ciaranello RD, Black IB (1971) Kinetics of the glucocorticoid-mediated induction of phenylethanolamine N-methyltransferase in the hypophysectomized rat. Biochem Pharmacol 20:3529–3532

    Google Scholar 

  • Ciaranello RD (1978) Regulation of phenylethanolamine N-methyltransferase synthesis and degradation I. Regulation by rat adrenal glucocorticoids. Mol Pharmacol 14:478–489

    Google Scholar 

  • Ciaranello RD, Wooten GF, Axelrod J (1975) Regulation of dopamine-β-hydroxylase in rat adrenal glands. J Biol Chem 250:3204–3211

    Google Scholar 

  • Ciaranello RD, Wooten GF, Axelrod J (1976) Regulation of rat adrenal dopamine-β-hydroxylase. II. Receptor interaction in the regulation of enzyme synthesis and degradation. Brain Res 113:349–362

    Google Scholar 

  • Coons Ah (1968) Fluorescent antibody methods. In: J.F. Danielli (ed) General cytochemical methods. Academic Press, NY 399–442

    Google Scholar 

  • Dairman W, Udenfriend S (1970) Increased conversion of tyrosine to catecholamine in the intact rat following elevation of tissue tyrosine hydroxylase levels by administered phenoxybenzamine. Mol Pharmacol 6:350–356

    Google Scholar 

  • Epelbaum J, Brazeau P, Tsang D, Brawer J, Martin JB (1977) Subcellular distribution of radioimmunoassayable somatostatin in rat brain. Brain Res 126:309–323

    Google Scholar 

  • Kessler JA, Adler JE, Bohn MC, Black IB (1981) Substance P in principle sympathetic neurons: regulation by impulse activity. Science 214:335–336

    Google Scholar 

  • Kimura S, Lewis RV, Stern AS, Rossier J, Stein S, Udenfriend S (1980) Probable precursors of [Leu] enkephalin and [Met] enkephalin in adrenal medulla: Peptides of 3–5 kilodaltons. Proc Natl Acad Sci (Wash) 77:1681–1685

    Google Scholar 

  • Lewis RV, Stern AS, Kimura S, Rossier J, Stein S, Udenfriend S (1980a) An about 50,000 — Dalton protein in adrenal medulla: a common precursor of [met] and [leu] enkephalin. Science 208:1459–1461

    Google Scholar 

  • Lewis RV, Stern AS, Kimura S, Stein S, Udenfriend S (1980b) Enkephalin biosynthetic pathway: Proteins of 8,000 and 14,000 daltons in bovine and adrenal medulla. Proc Natl Acad Sci (Wash) 77:5018–5020

    Google Scholar 

  • Lewis RV, Stern AS, Kilpatrick DL, Gerber LD, Rossier J, Stein S, Udenfriend S (1981) Marked increases in large enkephalin-containing polypeptides in the rat adrenal gland following denervation. J Neurose 1: 80–82

    Google Scholar 

  • Maickel RP, Westerman EO, Brodie BB (1961) Effects of reserpine and cold exposure on pituitary-adrenocortical function in rats. J Pharmacol Exp Ther 134:167–175

    Google Scholar 

  • Meyer JS, Micco DJ, Stephenson BS, Krey LC, McEwen BS (1979) A subcutaneous implantation method for chronic glucocorticoid replacement therapy. Physiol Behav 22:867–870

    Google Scholar 

  • Miller RJ, Chang K-J, Cooper B, Cuatrecasas P (1978) Radioimmunoassay and characterization of enkephalins in rat tissues, J Biol Chem 253:531–538

    Google Scholar 

  • Molinoff PB, Brimijoin S, Weinshilbaum R, Axelrod J (1970) Neurally mediated increase in dopamine-β-hydroxylase activity. Proc Natl Acad Sci (Wash) 66:453–458

    Google Scholar 

  • Mueller RA, Thoenen H, Axelrod J (1969) Increase in tyrosine hydroxylase activity after reserpine administration. J Pharmacol Exp Ther 169:74–79

    Google Scholar 

  • Patrick RL, Kirshner N (1971) Acetylcholine-induced stimulation of catecholamine recovery in denervated rat adrenals after reserpine-induced depletion. Mol Pharmacol 7:389–396

    Google Scholar 

  • Patrick RL, Kirshner N (1972) Developmental changes in rat adrenal tyrosine hydroxylase, dopamine-β-hydroxylase and catecholamine levels: effect of denervation, Dev Biol 29:204–213

    Google Scholar 

  • Schultzberg M, Lundberg JM, Hökfelt T, Terenius L, Brandt J, Elde RB, Goldstein M (1978) Enkephalin-like immunoreactivity in gland cells and nerve terminals of the adrenal medulla. Neuroscience 3:1168–1186

    Google Scholar 

  • Spinks A, Young EHP (1958) Polyalkylpiperidines: A new series of ganglion — blocking agents. Nature 181:1397–1398

    Google Scholar 

  • Stern AS, Lewis RV, Kimura S, Rossier J, Gerber LD, Brink L, Stein S, Udenfriend S (1979) Isolation of the opioid heptapeptide Met-enkephalin [Arg6, Phe7] from bovine adrenal medullary granules and striatum. Proc Natl Acad Sci (Wash) 76:6680–6683

    Google Scholar 

  • Thoenen H, Mueller RA, Axelrod J (1969) Increased tyrosine hydroxylase activity after druginduced alteration of sympathetic transmission. Nature 221:1264

    Google Scholar 

  • Vilar O, Tullman WW (1959) Effects of o, p ‘DDD’ on histology and 17-hydroxycorticosteroid output of the dog.

  • Viveros OH, Diliberto EJ, Jr, Hazum E, Chang K-J (1979) Opiate-like materials in the adrenal medulla: evidence for storage and secretion with catecholamines. Mol Pharm 16:1101–1108

    Google Scholar 

  • Viveros OH, Diliberto EJ Jr, Hazum E, Chang K-J (1980) Enkephalins as possible adrenomedullary hormones: storage, secretion, and regulation of synthesis. In: E Costa, M Trabucchi (eds) Neural Peptides and Neural Communication. Raven Press, NY, pp 191–204

    Google Scholar 

  • Wilson SP, Chang K-J, Viveros OH (1980) Synthesis of enkephalins by adrenal medullary chromaffin cells: reserpine increases incorporation of radiolabeled amino acids. Proc Natl Acad Sci (Wash) 77:4364–4368

    Google Scholar 

  • Wurtman RJ, Axelrod J (1966) Control of enzymatic synthesis of adrenaline in the adrenal medulla by adrenal cortical steroids. J Biol Chem 241:2301–2305

    Google Scholar 

  • Yang H-YT, DiGiulio AM, Fratta W, Hong JS, Majane EA, Costa E (1980) Enkephalin in bovine adrenal gland: multiple molecular forms [met5]-enkephalin immunoreactive peptides. Neuropharmacology 19:209–215

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported by the National Institutes of Health grants NS06400, NS10259, HD12108 and NS06801, and by grants from the Dysautonomia Foundation, the National Foundation — March of Dimes, and the Cerebral Palsy Association, M.C.B. is the recipient of a Research Career Development Award NS713, J.A.K. is the recipient of a Teacher Investigator Award NS00351, and I.B.B. is the recipient of the Irma T. Hirschl Career Scientist Award. We wish to thank Ms. Robyn Walsh for excellent technical assistance and Mrs. Bettye Mayer and Ms. Elise Grossman for preparation of the manuscript. Chlorisondamine was generously supplied by Ciba-Geigy Pharmaceutical Company

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bohn, M.C., Kessler, J.A., Golightly, L. et al. Appearance of enkephalin-immunoreactivity in rat adrenal medulla following treatment with nicotinic antagonists or reserpine. Cell Tissue Res. 231, 469–479 (1983). https://doi.org/10.1007/BF00218106

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00218106

Key words

Navigation